Please assess the completion status of the following clinical trial:

Trial Title: Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-89~* Acute renal failure or end-stage renal disease necessitating CRRT~* Admitted to the MICU service~* If on vasopressor/inotropic agent, norepinephrine as only intravenous pressor~* If on vasopressor/inotropic agent, at stable pressor dose for at least four hours~* If on IV fluids, stable dose of crystalloids \<= 100cc/hour and is not receiving colloids for 4 hours or more prior to initiation of CRRT~* Mean arterial pressure (MAP) \>= 65~* Arterial catheter present for continuous blood pressure monitoring~* CRRT duration of 48 hours or less using NxStage System One dialysis system~* successfully tolerated CRRT for at least 4 hours without clotting or hemodynamic instability~* no other procedures, blood products transfusion, or additional medication administration are anticipated during the study period~Exclusion Criteria:~* listed for organ transplant~* atrial fibrillation, other irregular heart rhythm, unstable arrhythmia~* need for more than one intravenous vasopressor agent~* intravenous vasopressor/inotropic agent other than norepinephrine (ie dobutamine, dopamine, vasopressin, epinephrine)~* therapeutic anticoagulation being administered~* known acute myocardial infarction as defined by elevated troponin along with a documented clinical diagnosis during current hospitalization~* known acute stroke, intracerebral hemorrhage, intracranial mass effect, or elevated intracranial pressure within the last 30 days.~* dialysis catheter malfunction and unable to maintain target blood flow rate~* fluid removal (ultrafiltration) rate \> 100mL/hour

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Experimental arm (Type: EXPERIMENTAL): The patients will have the blood flow rate adjusted on CRRT gradually increased to assess the effect on hemodynamics

Based on this trial design, predict the completion outcome and termination type (if applicable).